EssilorLuxottica has signed an agreement to acquire Espansione Group, the Italian manufacturer of Meibomask, a low-level light therapy (LLLT) device, and OPE (optimal power energy) intense pulsed light device, for patients with meibomian gland dysfunction, blepharitis or Sjögren syndrome and other c
Low-level light therapy (LLLT), also known as photobiomodulation, has recently become more widely accessible as a treatment for dry eye disease (DED) in New Zealand. LLLT is believed to work by triggering conformational changes in the cellular cytochrome-c oxidase enzyme, leading to enhanced mitocho
EssilorLuxottica has signed an agreement to acquire Espansione Group, the Italian manufacturer of Meibomask, a low-level light therapy (LLLT) device, and OPE (optimal power energy) intense pulsed ligh
This year's ADONZ conference did not disappoint with challenging and informative sessions plus DO extravaganza in spades.
A study from the University of Wuhan, China, has confirmed the association between meibomian gland dysfunction (MGD) and demodex infestation with the incidence of recurrent corneal erosion syndrome (R
Laughter matched drops for dry-eye relief, according a BMJ report on a study by Sun Yat-sen University, Xiamen University and Queen’s University Belfast. Results showed that laughter exercise wa
One-year study results from the phase 3 Essence-2 open-label extension (OLE) study for cyclosporine ophthalmic solution 0.1% (Vevye) have shown sustained safety and efficacy in treating the signs and symptoms of dry eye disease (DED).
Two new international research projects at the Ocular Surface Laboratory are testing the effectiveness and safety of commercially available treatments from Alcon’s Systane range for dry eye symptoms and discomfort due to contact lens (CL)-related dryness.
Anyone who has been pregnant or lived with someone who was pregnant knows that being expectant comes with its fair share of surprises – good and bad. Changes in the release of hormones such as oestrogen, progesterone, relaxin and others incite a chain reaction with subsequent changes in vascularity,
The Save Sight Dry Eye Registry (SSDER) was established by chief investigator Professor Stephanie Watson, head of the Corneal Research Group at the Save Sight Institute, University of Sydney, in 2020.
Dry eye disease (DED) is a highly prevalent condition that affects an estimated one in five adults1. However, early and accurate diagnosis of DED remains a clinical challenge as existing tests are invasive, time-consuming and inaccurate.
An Italian study showed that two sessions of low-level light therapy (LLLT) performed before and after cataract surgery were effective in ameliorating tear film stability and ocular discomfort symptom
